Last 7 days
2.2%
Last 30 days
2.4%
Last 90 days
6.4%
Trailing 12 Months
-23.5%
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-09-13 | Shaker Benjamin | acquired | 71,062 | 3.79 | 18,750 | chief markets officer |
2023-09-13 | Shaker Benjamin | sold | -337,455 | 17.9976 | -18,750 | chief markets officer |
2023-09-12 | Shaker Benjamin | acquired | 71,062 | 3.79 | 18,750 | chief markets officer |
2023-09-12 | Shaker Benjamin | sold | -338,481 | 18.0523 | -18,750 | chief markets officer |
2023-09-11 | Gertsch Timothy | sold | -488,616 | 18.6139 | -26,250 | chief accounting officer |
2023-09-11 | Gertsch Timothy | acquired | 196,700 | 7.49333 | 26,250 | chief accounting officer |
2023-08-16 | Gertsch Timothy | acquired | - | - | 5,603 | chief accounting officer |
2023-08-15 | Shaker Benjamin | acquired | 71,062 | 3.79 | 18,750 | chief markets officer |
2023-08-15 | Shaker Benjamin | sold | -339,309 | 18.0965 | -18,750 | chief markets officer |
2023-08-14 | Shaker Benjamin | sold | -351,082 | 18.7244 | -18,750 | chief markets officer |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-08-25 | Yarbrough Capital, LLC | unchanged | - | -97,451 | 263,620 | 0.01% |
2023-08-22 | COMERICA BANK | new | - | 2,000 | 2,000 | -% |
2023-08-22 | VIRGINIA RETIREMENT SYSTEMS ET AL | new | - | 279,174 | 279,174 | -% |
2023-08-21 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | added | 42.99 | 262,667 | 6,239,970 | 0.01% |
2023-08-21 | TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY | new | - | 1,774,000 | 1,774,000 | 0.02% |
2023-08-21 | BOKF, NA | sold off | -100 | -738,340 | - | -% |
2023-08-21 | OSAIC HOLDINGS, INC. | reduced | -42.49 | -1,209,470 | 855,529 | -% |
2023-08-17 | Durable Capital Partners LP | added | 9.68 | -26,041,700 | 104,658,000 | 0.92% |
2023-08-16 | Nuveen Asset Management, LLC | added | 41.19 | 390,558 | 13,051,600 | -% |
2023-08-16 | Neo Ivy Capital Management | new | - | 5,000 | 5,000 | -% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Sep 08, 2023 | morgan stanley | 10.7% | 43,556,373 | SC 13G/A | |
Sep 08, 2023 | wellington management group llp | 10.14% | 41,124,989 | SC 13G/A | |
Mar 10, 2023 | capital world investors | 10.3% | 42,425,420 | SC 13G/A | |
Feb 13, 2023 | capital world investors | 9.2% | 37,918,473 | SC 13G/A | |
Feb 08, 2023 | morgan stanley | 9.1% | 37,574,546 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 5.52% | 22,745,297 | SC 13G | |
Jan 10, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 14, 2022 | cd&r vector holdings, l.p. | 52.3% | 205,948,808 | SC 13G | |
Feb 11, 2022 | capital world investors | 9.1% | 35,865,953 | SC 13G | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G |
Date Filed | Form Type | Document | |
---|---|---|---|
Sep 14, 2023 | 4 | Insider Trading | |
Sep 13, 2023 | 4 | Insider Trading | |
Sep 12, 2023 | 144 | Notice of Insider Sale Intent | |
Sep 08, 2023 | SC 13G/A | Major Ownership Report | |
Sep 08, 2023 | SC 13G/A | Major Ownership Report | |
Aug 18, 2023 | 3 | Insider Trading | |
Aug 18, 2023 | 4 | Insider Trading | |
Aug 16, 2023 | 8-K | Current Report | |
Aug 16, 2023 | 4 | Insider Trading | |
Aug 08, 2023 | 10-K/A | Annual Report |
89.8%
82.8%
80.5%
Y-axis is the maximum loss one would have experienced if agilon health was unfortunately bought at previous high price.
Income Statement (Last 12 Months) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2018Q4 |
Revenue | 15.0% | 3,669,831,000 | 3,190,913,000 | 2,708,211,000 | 2,481,323,000 | 2,245,078,000 | 2,073,900,000 | 1,833,559,000 | 1,691,680,000 | 1,545,751,000 | 1,340,389,000 | 1,218,333,000 | 1,196,434,667 | 1,169,284,000 | 1,164,192,000 | 794,411,000 | 474,827,000 |
Operating Expenses | -100.0% | - | 3,304,340,000 | 2,828,642,000 | 2,580,509,000 | 2,350,347,000 | 2,456,480,000 | 2,227,511,000 | 2,077,502,000 | 1,905,816,000 | 1,403,343,000 | 1,275,006,000 | 1,219,008,000 | 1,183,456,000 | 1,187,528,000 | 900,985,000 | 546,891,000 |
S&GA Expenses | 12.0% | 275,532,000 | 245,957,000 | 218,945,000 | 197,578,000 | 192,241,000 | 457,878,000 | 455,821,000 | 448,073,000 | 431,798,000 | 148,485,000 | 137,292,000 | 122,961,333 | 123,706,000 | 110,420,000 | 122,832,000 | 88,745,000 |
EBITDA | 100.0% | - | -72,369,000 | -87,392,000 | -89,852,000 | -96,313,000 | -371,657,000 | -383,908,000 | -364,309,000 | -339,323,000 | -45,515,000 | -40,677,000 | -9,986,666 | -1,042,000 | -10,056,000 | -93,366,000 | -60,068,000 |
EBITDA Margin | 100.0% | - | -0.02 | -0.03 | -0.04 | -0.04 | -0.18 | -0.21 | -0.22 | -0.22 | -0.03 | -0.03 | -0.01 | 0.00 | -0.01 | -0.12 | -0.13 |
Interest Expenses | 12.4% | 5,830,000 | 5,187,000 | 4,525,000 | 3,656,000 | 3,523,000 | 4,076,000 | 6,146,000 | 7,259,000 | 8,345,000 | 8,927,000 | 8,135,000 | 8,242,667 | 8,458,000 | 8,596,000 | 9,068,000 | 9,839,000 |
Earnings Before Taxes | 5.1% | -87,408,000 | -92,144,000 | -105,689,000 | -106,994,000 | -113,787,000 | -390,223,000 | -404,598,000 | -386,161,000 | -361,690,000 | -68,202,000 | -62,343,000 | -31,377,333 | -22,534,000 | -31,444,000 | -114,687,000 | -81,292,000 |
EBT Margin | 100.0% | - | -0.03 | -0.04 | -0.04 | -0.05 | -0.19 | -0.22 | -0.23 | -0.23 | -0.05 | -0.05 | -0.03 | -0.02 | -0.03 | -0.14 | -0.17 |
Net Income | 4.3% | -87,861,000 | -91,761,000 | -106,553,000 | -106,808,000 | -111,983,000 | -390,179,000 | -406,487,000 | -373,981,000 | -349,965,000 | -59,031,000 | -60,052,000 | -47,782,666 | -48,020,000 | -64,396,000 | -282,588,000 | -146,926,000 |
Net Income Margin | 100.0% | - | -0.03 | -0.04 | -0.04 | -0.05 | -0.19 | -0.22 | -0.22 | -0.23 | -0.04 | -0.05 | -0.04 | -0.04 | -0.06 | -0.36 | -0.31 |
Free Cashflow | 100.0% | - | -183,480,000 | -146,234,000 | -145,083,000 | -165,958,000 | -140,999,000 | -154,723,000 | -116,283,000 | -99,305,000 | -69,513,000 | -54,979,000 | -54,829,333 | -72,878,000 | -105,888,000 | -106,753,000 | -69,632,000 |
Balance Sheet | (In Millions) | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2019Q4 |
Assets | 8.4% | 2,353 | 2,170 | 1,697 | 1,870 | 1,841 | 1,855 | 1,586 | 1,685 | 1,702 | 574 | 446 | 403 |
Current Assets | 9.0% | 2,045 | 1,876 | 1,451 | 1,634 | 1,601 | 1,628 | 1,367 | 1,453 | 1,480 | 418 | 294 | 246 |
Cash Equivalents | -51.6% | 191 | 394 | 497 | 551 | 684 | 1,022 | 1,055 | 1,082 | 1,109 | 105 | 135 | 139 |
Net PPE | 10.3% | 24.00 | 22.00 | 20.00 | 18.00 | 16.00 | 13.00 | 9.00 | 6.00 | 5.00 | 5.00 | 6.00 | 7.00 |
Goodwill | -0.1% | 62.00 | 62.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 | 42.00 |
Liabilities | 35.4% | 1,473 | 1,088 | 657 | 785 | 737 | 744 | 495 | 558 | 551 | 563 | 422 | 354 |
Current Liabilities | 40.1% | 1,362 | 973 | 535 | 658 | 605 | 610 | 357 | 423 | 412 | 372 | 267 | 200 |
LT Debt, Current | 0% | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 4.00 | - | 3.00 | 3.00 |
LT Debt, Non Current | -3.3% | 36.00 | 37.00 | 38.00 | 40.00 | 41.00 | 42.00 | 43.00 | 45.00 | 46.00 | 99.00 | 65.00 | 67.00 |
Shareholder's Equity | -18.6% | 880 | 1,082 | 1,041 | 1,086 | 1,103 | 1,111 | 1,092 | 1,127 | 1,150 | - | - | - |
Retained Earnings | -1.6% | -1,064 | -1,048 | -1,064 | -1,007 | -977 | -956 | -957 | -900 | -865 | -566 | -551 | -491 |
Additional Paid-In Capital | -8.6% | 1,947 | 2,130 | 2,107 | 2,095 | 2,076 | 2,064 | 2,046 | 2,025 | 2,012 | 266 | 264 | 257 |
Shares Outstanding | -2.2% | 405 | 414 | 412 | 412 | 407 | 402 | 400 | 391 | 377 | 326 | 249 | 295 |
Minority Interest | -6.8% | -0.72 | -0.67 | -0.61 | -0.53 | -0.46 | -0.37 | -0.30 | -0.28 | -0.17 | -0.07 | - | - |
Cashflow (Last 12 Months) | (In Millions) | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2018Q4 |
Cashflow From Operations | 23.2% | -129 | -168 | -130 | -129 | -151 | -130 | -148 | -112 | -97.82 | -67.90 | -53.20 | -53.15 | -71.00 | -104 | -103 | -67.53 |
Share Based Compensation | 34.2% | 51.00 | 38.00 | 28.00 | 23.00 | 27.00 | 295 | 292 | 290 | 279 | 7.00 | 7.00 | 6.00 | 6.00 | 4.00 | 5.00 | 4.00 |
Cashflow From Investing | 65.1% | -169 | -486 | -444 | -439 | -319 | -90.30 | -90.51 | -64.63 | -51.92 | 13.00 | 22.00 | -1.61 | -4.70 | 1.00 | -5.06 | -7.97 |
Cashflow From Financing | -901.5% | -183 | 23.00 | 28.00 | 37.00 | 29.00 | 1,138 | 1,154 | 1,143 | 1,136 | 28.00 | 25.00 | 34.00 | 63.00 | 109 | 176 | 85.00 |
Buy Backs | - | 806 | - | - | - | - | - | - | - | - | - | 7.00 | 27.00 | - | - | - | 2.00 |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 6 Months Ended | ||
---|---|---|---|---|
Jun. 30, 2023 | Jun. 30, 2022 | Jun. 30, 2023 | Jun. 30, 2022 | |
Revenues: | ||||
Revenues | $ 1,149,052 | $ 670,134 | $ 2,285,199 | $ 1,323,579 |
Expenses: | ||||
General and administrative (including noncash stock-based compensation expense of $19,572, $6,553, $33,244 and $10,523, respectively) | 81,499 | 51,924 | 148,345 | 91,758 |
Depreciation and amortization | 5,515 | 3,042 | 9,704 | 6,415 |
Total expenses | 1,178,873 | 691,186 | 2,308,759 | 1,345,374 |
Income (loss) from operations | (29,821) | (21,052) | (23,560) | (21,795) |
Other income (expense): | ||||
Other income (expense), net | 15,687 | 6,997 | 25,159 | 9,266 |
Gain (loss) on lease terminations | 0 | (5,458) | 0 | (5,458) |
Interest expense | (1,588) | (945) | (3,121) | (1,816) |
Income (loss) before income taxes | (15,722) | (20,458) | (1,522) | (19,803) |
Income tax benefit (expense) | (1,073) | (580) | 686 | (509) |
Income (loss) from continuing operations | (16,795) | (21,038) | (836) | (20,312) |
Discontinued operations: | ||||
Income (loss) before income taxes | 0 | 321 | 0 | 750 |
Income tax benefit (expense) | 0 | (14) | 0 | (14) |
Total discontinued operations | 0 | 307 | 0 | 736 |
Net income (loss) | (16,795) | (20,731) | (836) | (19,576) |
Noncontrolling interests’ share in (earnings) loss | 46 | 82 | 109 | 157 |
Net income (loss) attributable to common shares | $ (16,749) | $ (20,649) | $ (727) | $ (19,419) |
Net income (loss) per common share, basic and diluted | ||||
Continuing operations, basic (in dollars per share) | $ (0.04) | $ (0.05) | $ 0 | $ (0.05) |
Continuing operations, diluted (in dollars per share) | (0.04) | (0.05) | 0 | (0.05) |
Discontinued operations, basic (in dollars per share) | 0 | 0 | 0 | 0 |
Discontinued operations, diluted (in dollars per share) | $ 0 | $ 0 | $ 0 | $ 0 |
Weighted average shares outstanding | ||||
Basic (in shares) | 410,338 | 407,339 | 411,748 | 404,666 |
Diluted (in shares) | 410,338 | 407,339 | 411,748 | 404,666 |
Medical services revenue | ||||
Revenues: | ||||
Revenues | $ 1,147,044 | $ 669,184 | $ 2,281,874 | $ 1,321,607 |
Expenses: | ||||
Expenses | 1,008,734 | 587,140 | 1,981,561 | 1,153,348 |
Other operating revenue | ||||
Revenues: | ||||
Revenues | 2,008 | 950 | 3,325 | 1,972 |
Expenses: | ||||
Expenses | $ 83,125 | $ 49,080 | $ 169,149 | $ 93,853 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Jun. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 190,981 | $ 497,070 |
Restricted cash and equivalents | 10,204 | 10,610 |
Marketable securities | 389,046 | 411,901 |
Receivables, net | 1,417,052 | 497,574 |
Prepaid expenses and other current assets, net | 37,560 | 34,119 |
Total current assets | 2,044,843 | 1,451,274 |
Property and equipment, net | 24,407 | 20,050 |
Intangible assets, net | 94,185 | 67,680 |
Goodwill | 62,140 | 41,540 |
Other assets, net | 127,346 | 116,924 |
Total assets | 2,352,921 | 1,697,468 |
Current liabilities: | ||
Medical claims and related payables | 1,099,533 | 346,727 |
Accounts payable and accrued expenses | 257,819 | 183,364 |
Current portion of long-term debt | 5,000 | 5,000 |
Total current liabilities | 1,362,352 | 535,091 |
Long-term debt, net of current portion | 36,017 | 38,482 |
Other liabilities | 75,106 | 83,286 |
Total liabilities | 1,473,475 | 656,859 |
Commitments and contingencies | ||
Stockholders' equity (deficit): | ||
Common stock, $0.01 par value: 2,000,000 shares authorized; 405,427 and 412,385 shares issued and outstanding, respectively | 4,054 | 4,124 |
Additional paid-in capital | 1,947,438 | 2,106,886 |
Accumulated deficit | (1,064,957) | (1,064,230) |
Accumulated other comprehensive income (loss) | (6,369) | (5,560) |
Total agilon health, inc. stockholders' equity (deficit) | 880,166 | 1,041,220 |
Noncontrolling interests | (720) | (611) |
Total stockholders’ equity (deficit) | 879,446 | 1,040,609 |
Total liabilities and stockholders’ equity (deficit) | $ 2,352,921 | $ 1,697,468 |